| |
| |
|
| Insider
Information: |
Ho Carole |
| Relationship: |
Chief Medical Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
143,605 |
|
|
Indirect Shares
|
208,219 |
|
|
| Direct
Value |
$2,961,135 |
|
|
|
Indirect Value
|
$4,293,476 |
|
|
| Total
Shares |
351,824 |
|
|
| Total
Value |
$7,254,611 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
11
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Denali Therapeutics Inc. |
DNLI |
Chief Medical Officer |
2024-02-14 |
143,605 |
2024-02-14 |
208,219 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4/A |
AS |
$19.30 |
$118,084 |
I/I |
(5,950) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-04 |
4 |
AS |
$19.30 |
$118,084 |
D/D |
(5,950) |
2,777 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4 |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
142,615 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-01-02 |
4/A |
AS |
$19.43 |
$112,937 |
I/I |
(5,775) |
178,125 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2024-01-05 |
4 |
S |
$19.43 |
$193,756 |
I/I |
(9,972) |
198,777 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2020-03-30 |
4 |
S |
$19.48 |
$27,817 |
D/D |
(1,428) |
2,822 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
AS |
$19.93 |
$132,187 |
D/D |
(6,511) |
4,081 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-12-19 |
4 |
AS |
$20.00 |
$51,320 |
D/D |
(2,566) |
4,324 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-12-20 |
4 |
AS |
$20.00 |
$17,200 |
D/D |
(860) |
3,464 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-12-23 |
4 |
AS |
$20.01 |
$69,315 |
D/D |
(3,464) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-07-08 |
4 |
AS |
$20.21 |
$222,825 |
I/I |
(10,989) |
79,934 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2018-10-01 |
4 |
AS |
$21.72 |
$380,100 |
I/I |
(17,500) |
183,390 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-04 |
4 |
AS |
$21.87 |
$129,776 |
D/D |
(5,863) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-05 |
4 |
AS |
$21.96 |
$128,730 |
D/D |
(5,862) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.16 |
$73,483 |
I/I |
(3,316) |
103,806 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
AS |
$22.17 |
$129,495 |
D/D |
(5,775) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-10 |
4 |
AS |
$22.17 |
$56,445 |
D/D |
(2,546) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-21 |
4 |
S |
$22.60 |
$56,003 |
I/I |
(2,478) |
185,331 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.83 |
$73,438 |
I/I |
(3,210) |
107,122 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-09 |
4 |
AS |
$22.86 |
$60,792 |
D/D |
(2,653) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-23 |
4 |
AS |
$23.22 |
$58,561 |
I/I |
(2,522) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.50 |
$61,406 |
D/D |
(2,613) |
0 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-05-08 |
4 |
AS |
$23.51 |
$74,339 |
I/I |
(3,162) |
110,332 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2023-08-14 |
4 |
AS |
$23.79 |
$65,851 |
I/I |
(2,768) |
182,809 |
0 |
% |
|
| DNLI |
Denali Therapeutics Inc. |
Chief Medical Officer |
• – – |
2019-04-01 |
4 |
AS |
$23.91 |
$138,080 |
D/D |
(5,775) |
0 |
0 |
- |
|
108 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
